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a  b  s  t  r  a  c  t
The  onchocerciasis  transmission  models  EPIONCHO  and  ONCHOSIM  have  been  independently  devel-
oped  and  used  to  explore  the feasibility  of eliminating  onchocerciasis  from  Africa with  mass  (annual  or
biannual)  distribution  of  ivermectin  within  the  timeframes  proposed  by  the  World  Health  Organization
(WHO)  and endorsed  by the  2012  London  Declaration  on Neglected  Tropical  Diseases  (i.e. by  2020/2025).
Based  on the  ﬁndings  of  our  previous  model  comparison,  we implemented  technical  reﬁnements  and
tested  the  projections  of  EPIONCHO  and  ONCHOSIM  against  long-term  epidemiological  data  from  two
West  African  transmission  foci  in Mali  and  Senegal  where  the  observed  prevalence  of  infection  was
brought  to zero  circa 2007–2009  after  15–17  years  of mass  ivermectin  treatment.  We  simulated  these
interventions  using  programmatic  information  on  the  frequency  and  coverage  of mass  treatments  and
trained  the  model  projections  using  longitudinal  parasitological  data  from  27  communities,  evaluating
the  projected  outcome  of  elimination  (local  parasite  extinction)  or resurgence.  We  found  that  EPIONCHO
and  ONCHOSIM  captured  adequately  the  epidemiological  trends  during  mass  treatment  but that  resur-
gence, while  never  predicted  by  ONCHOSIM,  was  predicted  by  EPIONCHO  in some  communities  with  the
highest  (inferred)  vector  biting  rates  and  associated  pre-intervention  endemicities.  Resurgence  can  be
extremely  protracted  such  that  low  (microﬁlarial)  prevalence  between  1%  and 5% can  be  maintained  for
3–5 years  before  manifesting  more  prominently.  We  highlight  that  post-treatment  and post-elimination
surveillance  protocols  must  be implemented  for long  enough  and  with  high  enough  sensitivity  to  detect
possible  residual  latent  infections  potentially  indicative  of  resurgence.  We  also  discuss  uncertainty  and
differences  between  EPIONCHO  and  ONCHOSIM  projections,  the  potential  importance  of  vector  control
in high-transmission  settings  as a complementary  intervention  strategy,  and  the  short  remaining  time-
line  for  African  countries  to  be  ready  to stop  treatment  safely  and  begin  surveillance  in order to  meet  the
impending  2020/2025  elimination  targets.
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. Introduction
Human onchocerciasis or river blindness is caused by the
larial nematode Onchocerca volvulus and is earmarked for elim-
nation by the World Health Organization (WHO) as articulated
y the 2012 Roadmap (WHO, 2012) and the London Declaration
n Neglected Tropical Diseases (2012). The principal strategy to
chieve elimination is mass drug administration (MDA) with iver-
ectin. Ivermectin kills the skin-dwelling microﬁlariae (mf) that
re the progeny of adult O. volvulus and are infectious to biting
lackﬂy species vectors. Ivermectin may  also kill and/or steril-
ze adult worms  (Gardon et al., 2002). Multiple rounds of mass
reatment are effective in lowering the prevalence and intensity of
nchocerciasis and – if given for long enough at high enough cover-
ge – can lead to the interruption of transmission and elimination
f the infection. In Latin America, (biannual) MDA  has success-
ully eliminated onchocerciasis from Colombia (West et al., 2012),
cuador (Lovato et al., 2014), northern Venezuela (Convit et al.,
013) and Mexico (Rodríguez-Pérez et al., 2015), with Guatemala
waiting certiﬁcation. Good progress towards elimination has also
een made in Africa (Tekle et al., 2016) which bears 99% of the
nchocerciasis burden, with notable successes in regions of Mali,
enegal (Diawara et al., 2009; Traore et al., 2012), Nigeria (Tekle
t al., 2012), Sudan (Higazi et al., 2013) and eastern Uganda
Katabarwa et al., 2014) but also conspicuous regions of ongoing
ransmission despite years of intervention in Ghana (Lamberton
t al., 2015), Cameroon (Katabarwa et al., 2013a; Wanji et al., 2015;
isenbarth et al., 2016) and northwestern Uganda (Katabarwa et al.,
013b), and evidence of recrudescence in Burkina Faso (Koala et al.,
017).
EPIONCHO and ONCHOSIM are mathematical transmission
odels of human onchocerciasis that have been used to evalu-
te the effectiveness of different intervention strategies in reaching
he 2020/2025 elimination targets for onchocerciasis (WHO, 2012;
POC, 2012). Both models have been used to predict the time to
liminate onchocerciasis under annual or biannual MDA  (Coffeng
t al., 2014a; Turner et al., 2014), and have been used in col-
aboration with the African Programme for Onchocerciais Control
APOC) to evaluate how progress towards elimination can be accel-
rated by implementing alternative treatment strategies (WHO,
015). ONCHOSIM has been used to inform the Onchocerciasis Con-
rol Programme in West Africa (OCP) and the African Programme
or Onchocerciasis Control on expected trends of infection during
ector control (Plaisier et al., 1991), mass ivermectin treatment
Winnen et al., 2002; Coffeng et al., 2014a; Tekle et al., 2016) or
heir combination (Plaisier et al., 1997), the health impact of the
nterventions (Coffeng et al., 2014b), and the expected time to elim-
nation (Kim et al., 2015).
More recently, the developers of EPIONCHO and ONCHOSIM
ave started to compare and reﬁne their models, with the objec-
ive of reaching consensus on the feasibility of and time horizons
or elimination, and optimum interventions for achieving the
HO  goals in Africa (Stolk et al., 2015). The ﬁrst formal com-
arison, which attempted to ‘dock’ the two models by making
arameter assumptions as equivalent as possible, revealed some
mportant differences between the models’ structural assumptions
nd resulting outputs. Both models demonstrated a beneﬁt of bian-
ual versus annual treatment but differed in their predicted time
o elimination, particularly when using transmission breakpoints
s endpoints rather than operational (microﬁlarial) prevalence
hresholds such as those provisionally proposed by APOC (2010).
ne of the conclusions of this ﬁrst comparison was  that the use of a
ingle prevalence threshold across different endemicity (transmis-
ion intensity) settings may  not be appropriate and needs further
nvestigation (Stolk et al., 2015).ics 18 (2017) 4–15 5
The epidemiology of onchocerciasis has changed as a result of
the introduction of ivermectin MDA, which means that EPIONCHO
and ONCHOSIM are now being used in transmission contexts far
from those in which they were originally developed and parame-
terized (Basán˜ez and Boussinesq, 1999; Plaisier et al., 1991; Plaisier
et al., 1995). Hence, to maintain conﬁdence in projections, these
models must be tested and validated against data collected before,
during and after MDA, reﬂecting the spectrum of transmission con-
ditions, from endemic infection to transmission interruption and
elimination (Basán˜ez et al., 2012a,b). Given the prolonged nature of
onchocerciasis interventions, capturing and recording such data is
challenging and resource-intensive and would probably have been
impossible without the logistical and technical support of the OCP
and APOC.
Here we test the EPIONCHO and ONCHOSIM models against
epidemiological data collected over two  decades from 27 sentinel
communities in two onchocerciasis foci in Mali and Senegal. In
these foci, MDA  with ivermectin alone has successfully brought the
prevalence of infective larvae (in blackﬂies) and of mf (in humans)
– detectable by skin snips – to zero, indicative of elimination
(Diawara et al., 2009; Traore et al., 2012). In particular, prevalence of
skin mf  reached the previously proposed operational thresholds set
by APOC of <5% in all surveyed villages and <1% in 90% of those sur-
veyed (APOC, 2010). We  use programmatic data on the frequency
and coverage of MDA  with ivermectin to simulate these interven-
tions from endemic baseline, circa 1987, through to cessation of
treatment, circa 2006, and then beyond, projecting forwards to
2020. We  train the model projections using subsets of epidemiolog-
ical data comprising community-speciﬁc estimates of microﬁlarial
prevalence collected throughout the intervention. We  determine
whether the models predict sustained elimination or resurgence
of infection in the post-treatment and post-elimination periods
(WHO, 2016) and explore how these predictions change when
using increasing amounts of epidemiological training data, from
pre-intervention data only to multiple longitudinal data points per
community.
2. Models and methods
2.1. EPIONCHO
EPIONCHO is a deterministic onchocerciasis transmission model
that uses partial differential equations to describe changes (with
respect to time and host age) in mean number of fertile and non-
fertile female adult worms per host, mean number of mf  per
milligram (mg) of skin in humans and mean number of larvae per
simuliid (blackﬂy) vector. Brieﬂy, the model is based on a proto-
type presented by Basán˜ez and Boussinesq (1999), and extended to
include age and sex structure of the human population (Filipe et al.,
2005); the temporal dynamics of mf  following ivermectin treat-
ment (Basán˜ez et al., 2008), and increased programmatic realism
related to patterns of treatment coverage and systematic non-
adherence (Turner et al., 2013). The model allows for age- and
sex-speciﬁc patterns of exposure to blackﬂy bites (Filipe et al.,
2005) and variation in adherence to treatment. The latter is mod-
elled by partitioning the population into four groups, namely, a
full adherence group that takes treatment every round; two  semi-
adherent groups that take treatment every other round alternately,
and a systematically non-adherent group that never takes treat-
ment. Treatment with ivermectin is assumed to kill 98–99% mf,
temporarily sterilize adult female worms  and cumulatively reduce
their capacity to produce mf  (Basán˜ez et al., 2008; Turner et al.,
2013). EPIONCHO has been used to address public health pol-
icy questions including an economic evaluation of implementing
community-directed treatment with ivermectin (CDTI) biannually
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Fig. 1. Endemic microﬁlarial prevalence (before intervention) in selected sentinel communities in (a) the River Bakoye focus, Mali and (b) the River Gambia focus, Senegal
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nd  coloured sequentially from yellow to red. Error bars denote 95% conﬁdence int
ompared to annually (Turner et al., 2014); the potential epidemi-
logical impact of MDA  with moxidectin (Turner et al., 2015a), and
he future deployment of an onchocerciasis vaccine (Turner et al.,
015b).
The latest version of EPIONCHO used here incorporates a num-
er of reﬁnements from the version described in Turner et al. (2013)
nd reviewed by Basán˜ez et al. (2016). Some of these are moti-
ated by the results of our recent comparison with ONCHOSIM
Stolk et al., 2015), and others by our improved understanding of
he population biology of O. volvulus. Modiﬁcations include: (1) the
ntroduction of a latent period for the development of O. volvu-
us within the blackﬂy vector, implemented by dividing the larval
tate L into L1,  L2 and L3 compartments (Basán˜ez et al., 2007;
asán˜ez et al., 2009); (2) a reparameterization of the microﬁlarial
uptake’ curve (describing parasite establishment within the vec-
or) to reﬂect that an overdispersed distribution of parasites among
uman hosts affects the overall severity of density dependence
Churcher et al., 2005); (3) a new functional relationship between
he prevalence and intensity of mf  that reﬂects the underlying dis-
ribution of adult worms, incorporates the sensitivity of skin snips
Bottomley et al., 2016) and better captures the initial ‘bounce back’
f microﬁlarial prevalence during the ﬁrst few rounds of ivermectin
DA  (Plaisier et al., 1995); and (4) a more realistic distribution
f adult parasite survival times (previously exponential), imple-
ented by introducing multiple nominal ‘age’ compartments for
dult O. volvulus and parameterised using published estimates of
ife expectancy as well as the ‘tail’ of the distribution of survival
imes (Plaisier et al., 1991). Full details of these reﬁnements and
he complete description of this latest version of EPIONCHO are
iven in the Supplementary information, 1.1 EPIONCHO and a list
f parameter deﬁnitions, descriptions and values in Supplementary
nformation, Table S1.
.2. ONCHOSIM
ONCHOSIM is a long-established microsimulation model of
nchocerciasis transmission (Habbema et al., 1996; Plaisier et al.,
990). Brieﬂy, the model considers a human population, typically
onsisting of approximately 400 individuals, with a demographic
omposition that changes stochastically over time. The life-
istories of individual male and female adult parasites and the
opulations of mf  within individual human hosts are tracked and
ransmission is mediated by a population of blackﬂies (the parasite-
ithin-the-vector component is treated deterministically). The
urvival times of adult worms follow a Weibull distribution. The years of <40% (hypoendemic), 40%–59% (mesoendemic) and ≥60% (hyperendemic)
. Community names are anonymised.
biting rate (number of bites per person per unit time) is seasonal,
varies among hosts according to an individual-speciﬁc exposure
variable (assigned at birth), and changes systematically with host
age and sex in a manner similar to that of EPIONCHO. Treatment in
ONCHOSIM is modelled in a broadly similar manner to EPIONCHO,
albeit (100%) mf  are killed instantaneously in ONCHOSIM rather
than over 1–2 months as in EPIONCHO and the rates at which
female worms recover their fertility are subtly different between
the two models (Plaisier et al., 1995; Basán˜ez et al., 2008; Coffeng
et al., 2014a; Basán˜ez et al., 2016). Human hosts, excluding children
aged <5 years and a fraction of women of reproductive age, partic-
ipate in each round of MDA  with a probability that depends on
age and sex, and a parameter governing their lifelong adherence to
MDA. ONCHOSIM has been used to inform and support OCP (Plaisier
et al., 1997; Winnen et al., 2002) and APOC (Coffeng et al., 2014a,b)
intervention policies and more recently has been used to evaluate
the progress of APOC projects targeting elimination (Tekle et al.,
2016). Technical details of the ONCHOSIM model can be found in
Supplementary information, 1.2 ONCHOSIM, Coffeng et al. (2014a)
and Basán˜ez et al. (2016). The ONCHOSIM parameter deﬁnitions,
descriptions and values are given in Supplementary information,
Table S2.
2.3. Epidemiological and programmatic data
We  use long-term parasitological and programmatic data from
the River Bakoye and River Gambia foci in Mali and Senegal where
onchocerciasis has been declared eliminated after 15–17 years of,
respectively, annual or biannual MDA  (Diawara et al., 2009; Traore
et al., 2012) (Fig. 1). We  do not use data from the cross-border River
Faleme focus. The predominant blackﬂy vector species in both foci
is Simulium sirbanum (a savannah member of the S. damnosum s.l.
complex; Boakye et al., 1998). Sentinel communities were initially
selected by the OCP circa 1987 in areas of the Western Extension
where vector control had never been implemented and therefore
provided a unique opportunity to evaluate the impact of ivermectin
as the sole measure of control. Communities were routinely mon-
itored by the OCP from 1987 to 2002 and from 2006 by a team
studying the feasibility of eliminating onchocerciasis with MDA
alone (Diawara et al., 2009).
The epidemiological data comprise community-speciﬁc
sequences of microﬁlarial prevalence estimates. These estimates
are based on the detection, by skin snips, of mf  in all those aged
1 year and older using standard OCP protocols (the observation
of at least one microﬁlaria in 2 skins snips incubated in distilled
M. Walker et al. / Epidemics 18 (2017) 4–15 7
Table  1
Summary of epidemiological data on community prevalence of microﬁlariae.
Focus, country Number of
communities
Endemic microﬁlarial prevalence
before intervention (range)
Sequence length of microﬁlarial
prevalence training data (range)
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pRiver Bakoye, Mali 13 31%–7
River  Gambia, Senegal 14 36%–8
ater for at least 30 min, but for 24 h if negative after this time)
nd standardized by age and sex using the OCP reference popu-
ation (Moreau et al., 1978). Because young children tend to be
nderrepresented in community skin-snip surveys, we assumed
hat the data better represented the prevalence in those aged
5 years rather than ≥1year, thereby harmonizing the sampled
emographic group with usual EPIONCHO and ONCHOSIM outputs
Stolk et al., 2015). We  excluded from our analysis communities
here only pre- or post-intervention data were available (Table 1).
The programmatic data comprise estimates, within a range, of
he overall therapeutic coverage (proportion of the total popula-
ion treated) with ivermectin within each river basin for the periods
988–1991, 1992–1996 and 1998–2006 (Table 2). Ivermectin was
rst distributed by OCP mobile teams before CDTI – which empow-
red communities to appoint local community-drug distributors
ho took responsibility for distributing ivermectin – was  intro-
uced in 1997, following the inception of APOC in 1995 (Boatin,
008). There is a notable drop in coverage in the ﬁrst year of CDTI
Table 2) associated with logistical challenges in changing the dis-
ribution system (Diawara et al., 2009).
.4. Simulating interventions and estimating community-speciﬁc
iting rates
We  simulated MDA  interventions using the (focus-speciﬁc) pro-
rammatic data on frequency and coverage summarized in Table 2.
oth EPIONCHO and ONCHOSIM are initialized using the annual bit-
ng rate (ABR), deﬁned here as the average number of blackﬂy bites
eceived per person per year. Hence, to run community-speciﬁc
imulations, we required an estimate of the ABR in each com-
unity. We  estimated ABRs by a maximum likelihood approach
Supplementary information, 1.4 Estimating community-speciﬁc
iting rates) using subsets of the microﬁlarial prevalence time
eries from each community. We  refer to these subsets as training
atasets, each comprising a variable sequence length of longitu-
inal prevalence estimates from each community. The smallest
raining dataset comprised pre-intervention data only and the
argest included all data from all communities. We  iteratively
e-estimated ABRs by incrementally increasing the length of the
ongitudinal training datasets, evaluating how increasing amounts
f training data altered and inﬂuenced the model projections. Data
n the exact time of treatment (unlike the time of epidemiological
urveys) were not available and hence, for the purposes of estimat-
ng ABRs, we assumed that surveys were undertaken exactly 11 or
 months after the last treatment for, respectively, the annual and
iannual distributions in the River Bakoye and River Gambia foci
Supplementary information, Table S3).
.5. Parametric uncertainty
The estimation of ABRs depends on its relationship with infec-
ion which, in turn, depends on structural assumptions and
arameter values of the model. In ONCHOSIM, we estimated ABRs,
ccounting for seasonality in transmission, while all other param-
ters were ﬁxed at their default values (Coffeng et al., 2014a;
asán˜ez et al., 2016). In EPIONCHO, we explicitly considered that
here is uncertainty in some essential parameters: multiple unique
arameter sets are all concordant with an independent dataset3–5
4–11
comprising coupled pre-intervention community-level prevalence
and ABR estimates from Cameroon (Renz and Wenk, 1987; Basán˜ez
and Boussinesq, 1999) (Fig. 2a). We  identiﬁed these parameter sets
using a sampling importance resampling (SIR) approach (Gambhir
et al., 2015), in which we sampled from the posterior distribution
of parameter values given uniform priors deﬁned by the ranges
of published estimates (Supplementary information, Table S1).
Details of this approach are given in Supplementary information,
1.3 Parametric uncertainty.
2.6. Selection of a maximum a posteriori parameter set
The SIR approach applied to EPIONCHO involves deﬁning a prior
distribution for discrete parameter sets, thereby supporting a wide
range of model projections for an estimated ABR. We  calculated
the posterior probability of each community projection as the like-
lihood of the combined training dataset from all communities (i.e.
a single combined dataset for each focus) weighted by the param-
eter set (prior) probability calculated from the SIR procedure. For a
more direct comparison with ONCHOSIM – in which we only con-
sider a single default parameter set – we selected the parameter
set that maximised the posterior probability, akin to a maximum
a posteriori (MAP) approach. Details are given in Supplementary
information, 1.5 Selecting maximum a posteriori (MAP) parameter
sets. We  highlight that, unlike the estimation of ABRs, undertaken
on a community basis, identiﬁcation of MAP  parameter sets was
done at the regional level (i.e. including both foci); fundamen-
tal biological and population dynamics parameters were assumed
constant among communities and between foci (but ABRs were
permitted to vary).
2.7. Elimination criterion
We evaluated the outcome of each community-based simula-
tion as sustained elimination or resurgence according to the MAP
parameter sets for EPIONCHO and the default parameter set for
ONCHOSIM. We  deﬁned sustained elimination as local parasite
extinction, indicated by the parasite population tending termi-
nally to zero. If elimination is not sustained, resurgence occurs.
In EPIONCHO, sustained elimination arises by crossing the trans-
mission breakpoint. This arises because of the necessity for female
O. volvulus to mate to produce mf  (modelled by the so-called
mating probability (May, 1977), Supplementary information, 1.1
EPIONCHO). The population density below this threshold becomes
unsustainably low and tends to extinction (evaluated numerically
as when the mean number of adult worms immediately after the
last treatment is greater than the corresponding value 20 years
later, i.e. indicative of terminal decline). The mating probability
is governed by the assumed sex ratio, the parasite mating sys-
tem (assumed to be polygamous, whereby one male can mate
all females within a single host; Schulz-Key and Karam, 1986;
Hildebrandt et al., 2012) and the degree of (adult) worm overdis-
persion among hosts which is included as an uncertain parameter
in our SIR approach (Supplementary information, 1.3 Parametric
uncertainty). In ONCHOSIM the breakpoint (also determined by
the assumed polygamous mating system and the degree of worm
overdispersion) operates in combination with chance elimination
of the parasite population caused by demographic stochastic-
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Table  2
Summary of programmatic data on community coverage with ivermectin.
Focus, country Time period Treatment frequency Treatment coverage
River Bakoye, Mali 1989–1991 Annual 59%–62%
1992–1996 Annual 75%–78%
1997 Annual ∼38%b
1998–2006 Annual 73%–83%
River  Gambia, Senegal 1988–1991 Annual/biannuala 64%–69%
1992–1996 Biannual 76%–77%
1997 Biannual ∼38%b
1998–2006 Biannual 77%–81%
a Annual 1988–1990; biannual thereafter.
b First year of community-directed treatment with ivermectin, coverage was low (Diawara et al., 2009) and here is assumed to be half that of the preceding period.
Fig. 2. Modelled relationship between annual biting rate (ABR) of blackﬂy vectors and endemic microﬁlarial prevalence using (a) EPIONCHO and (b) ONCHOSIM. In panel (a),
the  coupled ABR-prevalence data are from 9 communities in northern Cameroon (Basán˜ez and Boussinesq, 1999) where each ABR was  measured as an average from multiple
years  and locations within and around each community, weighted by the proportion of time community residents spent at these locations (Renz and Wenk, 1987). Each thin
line  corresponds to an EPIONCHO parameter set identiﬁed by the sampling importance resampling (SIR) procedure described in Supplementary information, 1.3 Parametric
uncertainty. These are coloured sequentially from yellow to red in accordance with endemicity category as deﬁned by a microﬁlarial prevalence in people aged ≥5 years of
<40%  (hypoendemic), 40%–59% (mesoendemic) and ≥60% (hyperendemic). The thick black line corresponds to the parameter set that achieved the highest likelihood. Inset
is  the same graph with the x-axis transformed to a logarithmic scale. In panel (b), the thin lines correspond to stochastic realizations of the ONCHOSIM default parameter set
(  the t
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TCoffeng et al., 2014a), coloured sequentially according to endemicity category, and
re  not shown in panel (b) because ONCHOSIM has not been re-ﬁtted to these data
ty in the human host population, a non-negligible phenomenon
ecause of the relatively small simulated human population size
f 400–440 individuals (see Supplementary information, Table S2).
either EPIONCHO nor ONCHOSIM consider possible reintroduc-
ion of infection (by blackﬂies or humans) from proximate foci
here transmission maybe ongoing.
.8. Coverage and adherence
We  repeated the simulations, re-estimating ABRs (and for
PIONCHO, identifying MAP  parameter sets) and evaluating pro-
ections of sustained elimination or resurgence using different
ssumed values of the estimated treatment coverage, which was
iven as within the ranges shown in Table 2. Speciﬁcally, we  ran
epeated simulations using the lower, median and upper estimates
f coverage within each timeframe (Table 2). The degree of non-
dherence to MDA  was unknown and was set to 5% for both models,
n accordance with previous simulations (Stolk et al., 2015).
. Results
.1. Infection dynamics towards eliminationWe  present in Fig. 3 the observed microﬁlarial prevalence and
he EPIONCHO- and ONCHOSIM-modelled dynamics in the River
akoye focus in Mali and in the River Gambia focus in Senegal.
he simulations shown are those with estimated community-hick black line is the median of 500 simulations. The coupled ABR-prevalence data
speciﬁc ABRs that maximise the likelihood of the community
training datasets using pre-intervention microﬁlarial prevalence
data only (Fig. 3a, b, e and f) or the complete longitudinal train-
ing dataset sequence from each community (Fig. 3c, d, g and
h; the additional ﬁts to each sequence length of longitudinal
data are shown in the Supplementary information, Figs. S1 and
S2; the maximum likelihoods of the data given the estimated
community-speciﬁc ABRs are presented in Supplementary infor-
mation, Table S4). We  present EPIONCHO projections for MAP
parameter sets for a viz-a-viz comparison with the ﬁxed param-
eter set used by ONCHOSIM. In the River Bakoye focus, under
annual ivermectin, EPIONCHO predicts a slightly faster initial
decline in prevalence than ONCHOSIM. This is not apparent in
the River Gambia focus under biannual treatment. Nevertheless,
both models adequately capture the long-term broad trends in
the data from pre-intervention endemic prevalence, through the
treatment phase towards elimination. It is noteworthy that, in
general, the estimated community-speciﬁc ABRs (and the corre-
sponding model-derived pre-intervention endemicity) decrease
with increasing longitudinal training dataset sequences. This is
particularly apparent for the EPIONCHO projections in the River
Bakoye focus where, when using the complete training dataset, no
communities are predicted as being hyperendemic (i.e., no pre-
intervention microﬁlarial prevalence ≥60%, Fig. 3c) despite ﬁve
communities being putatively classiﬁed as such (although only
one statistically signiﬁcantly so) using pre-intervention data only
(Fig. 1).
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Fig. 3. Observed and modelled dynamics of microﬁlarial prevalence in 13 communities from the River Bakoye focus, Mali (panels a–d) and in 14 communities from the
River  Gambia focus, Senegal (panels e–h). Panels on the left (a, c, e and g) and on the right (b, d, f and h) show EPIONCHO and ONCHOSIM projections, respectively. The thin
lines  correspond to community-speciﬁc simulations using maximum likelihood estimates of the community-speciﬁc annual biting rates (ABRs) and either the maximum a
posteriori (MAP) parameter set (EPIONCHO) or the default parameter set (ONCHOSIM). The estimated ABRs and MAP  parameter sets are derived using the pre-intervention
microﬁlarial prevalence data only (a, b, e and f) or using the complete longitudinal sequence for each community (c, d, g and h). For brevity, the dynamics predicted from
estimates using one or two interim time points are not shown. For ONCHOSIM there are many stochastic projections for each community projection; for EPIONCHO there is
a  single deterministic projection for each community, corresponding to the MAP  parameter set. The thick solid lines show the median dynamics by endemicity category as
categorised by a model-derived pre-intervention microﬁlarial prevalence in people aged ≥5 years of <40% (hypoendemic), 40%–59% (mesoendemic) and ≥60% (hyperendemic)
a  EPION
i  show
a
3
w
e
i
d
o
O
g
tnd  coloured sequentially from yellow to red. In panel c the estimated ABRs (from
n  the River Bakoye focus were either hypoendemic or mesoendemic. Panel insets
ppraisal of the model projections compared to the data close to zero.
.2. Elimination or resurgence
We  present in Fig. 4 the number and percentage of communities
here the EPIONCHO-predicted outcome of MDA  was sustained
limination (local parasite extinction) using incrementally increas-
ng subsets of the longitudinal training datasets (Table 1) and
ifferent assumed levels of treatment coverage within the range
f reported estimates (Table 2). The percentage of (stochastic)
NCHOSIM projections resulting in sustained elimination was
reater than 99% for all communities, irrespective of the length of
he training datasets. By contrast, EPIONCHO projections were vari-CHO, using the complete longitudinal data sequences) indicated all communities
 the period between 2010 and 2020 using a transformed y-axis for a better visual
able. Longer training datasets resulted in more communities with
a prediction of sustained elimination in the River Bakoye focus. In
the River Gambia focus the length of the training data made little
difference to the outcome of sustained elimination or resurgence. It
is noteworthy that in some instances, there are more communities
with a prediction of elimination when lower levels of treatment
coverage were assumed (Fig. 4b). This reﬂects parametric uncer-
tainty in the model projections since different MAP parameter sets
could be selected when estimating community-speciﬁc ABRs using
different training data subsets and different assumed levels of treat-
ment coverage.
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Fig. 4. Number and percentage of community-speciﬁc EPIONCHO projections resulting in elimination in (a) the River Bakoye focus, Mali and (b) the River Gambia focus,
Senegal. Each grid element indicates the number and percentage of communities with a projected outcome of sustained elimination when training the model projection
using different sequence lengths of the community-speciﬁc microﬁlarial prevalence estimates (x-axis, see Table 1) and assuming different levels of coverage (y-axis, see
Table 2). The outcomes are coloured sequentially from red (50% of communities with predicted elimination) to green (100% of communities with predicted elimination).
Fig. 5. The percentage of communities with an EPIONCHO-projected outcome of sustained elimination in (a) 13 communities in the River Bakoye focus, Mali and (b)
14  communities in the River Gambia focus, Senegal. Endemicity is categorized according to the model-derived pre-intervention microﬁlarial prevalence estimates (using
the  estimated community-speciﬁc annual biting rates) in people aged ≥5 years of <40% (hypoendemic), 40%–59% (mesoendemi) and ≥60% (hyperendemic) and coloured
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tequentially from yellow to red. Each bar indicates the combined results from estima
sing different sequence lengths of the community training datasets (Table 1) and d
he  pre-intervention endemicity was estimated as hyperendemic, the chance of elim
Generally, in EPIONCHO the outcome of sustained elimination
s sensitive to the model-derived endemicity, as driven by the esti-
ated community-speciﬁc ABRs. Fig. 5 shows that – regardless of
he length of the training dataset or the assumed level of cover-
ge – sustained elimination was rarely predicted in hyperendemic
ommunities (where the pre-intervention endemic microﬁlarial
revalence was estimated to be ≥60%; a slightly higher percentage
f simulations with pre-intervention hyperendemicity occurred in
he River Gambia focus, Senegal compared with the River Bakoye
ocus, Mali because of the biannual treatment strategy). When
limination is predicted, the rate of resurgence is variable but some-
imes very protracted, depending on community endemicity (and
he corresponding ABR). We  illustrate this in Fig. 6 by showing the
PIONCHO-predicted microﬁlarial prevalence levels in 2007, 2009
nd 2012 – one, three and ﬁve years after the last round of treatment
n 2006 – among communities where either sustained elimination
microﬁlarial prevalence tending to zero) or resurgence was indi-
ated. Many of the simulations predict a microﬁlarial prevalence
etween 1% and 5% at these times in communities where infection
s (slowly) resurgent.. Discussion
We  have tested the EPIONCHO and ONCHOSIM onchocerciasis
ransmission models against long-term epidemiological data fromhe community annual biting rate (and the subsequent pre-intervention endemicity)
nt assumed levels of treatment coverage (Table 2). Hence, in any simulation where
on was  low, irrespective of the annual (a) or biannual (b) treatment strategy.
two foci in Mali and Senegal where the (detectable) prevalence of
O. volvulus mf  has been brought to zero by, respectively, annual
and biannual MDA  with ivermectin alone. Both models capture
adequately community infection dynamics through MDA  towards
elimination. Elimination in all 27 communities is the ubiquitous
outcome predicted by ONCHOSIM, irrespective of inferred vector
biting rates and uncertain coverage. In EPIONCHO, elimination is
less certain, being dependent on the inferred community-speciﬁc
blackﬂy biting rates (ABRs) and corresponding (model-derived)
levels of infection endemicity. In the more highly endemic com-
munities in the River Gambia focus, Senegal – with the highest
vector biting rates – EPIONCHO indicates a substantive risk of infec-
tion resurgence, despite the biannual MDA  strategy. Resurgence
dynamics can be very protracted such that the microﬁlarial preva-
lence often remains between 1% and 5% for at least ﬁve years after
the last treatment, before rising more substantively.
The model-predicted protracted nature of possible resurgence
has important implications for the design of elimination-
veriﬁcation protocols, post-treatment surveillance (PTS) and
post-elimination surveillance (PES). Notwithstanding the new
WHO  guidelines (WHO, 2016) for verifying elimination – which
recommend serological surveillance of children (possibly in combi-
nation with skin snipping) and entomological monitoring during at
least three years of post-treatment surveillance (PTS) (Golden et al.,
2016) – hitherto in Africa, monitoring, evaluation and surveillance
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Fig. 6. EPIONCHO predictions of microﬁlarial prevalence in 2007, 2009 and 2012, one, three and ﬁve years after the last round of treatment in 2006, among communities in
(a–c)  the River Bakoye focus, Mali and (d–f) the River Gambia focus, Senegal. Endemicity is categorized according to model-derived pre-intervention microﬁlarial prevalence
estimates (using the estimated community-speciﬁc annual biting rates) in people aged ≥5 years of <40% (hypoendemic), 40%–59% (mesoendemic) and ≥60% (hyperendemic)
and  coloured sequentially from yellow to red. Each category includes the combined results from estimating the community annual biting rate (ABR) and the subsequent
pre-intervention endemicity using different sequence lengths of the community training datasets (Table 1) and different assumed levels of treatment coverage (Table 2).
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whe  circular data points in each panel indicate simulations where resurgence is the
ata  points (all close to 0%) are those corresponding to sustained elimination. The vi
ashed lines represent nominal (operational) microﬁlarial prevalence thresholds of
ave still mostly been based on skin snipping to detect mf. APOC
et operational prevalence thresholds for stopping treatment and
tarting surveillance (<5% microﬁlarial prevalence in all surveyed
illages and <1% in 90% of those surveyed) that should be met  for a
hree-year PTS period to conﬁrm elimination (APOC, 2010). Indeed,
he progress of 54 APOC project areas (comprising clusters of 5–20
illages) targeting these thresholds has recently been evaluated
y comparing observed microﬁlarial prevalence versus ONCHOSIM
redictions (Tekle et al., 2016), with 46/54 (85%) judged on track or
xceeding prediction in their progress towards PTS. The protracted
ature of some of the resurgence dynamics indicated by EPIONCHO,
nitially characterized by latent, difﬁcult-to-detect infections lev-
ls before more marked increases, suggests that the proposed 3–5
ears of PTS (APOC, 2010; WHO, 2016) must be extremely robust –
nd include optimized and efﬁcient sampling methodologies – to
e effective in identifying the early signs of infection resurgence.
his also means that for African countries to conﬁrm elimination by
020 (WHO, 2012) or 2025 (APOC, 2012) they will need to be in a
osition to stop treatment safely either imminently or at the latest
y 2022. For many African countries, the former is unlikely. Meet-
ng the latter 2022 stopping-treatment date will require careful
onitoring and evaluation of progress.
Critically, the resurgence dynamics projected by EPIONCHO are
ntimately linked with the (poor) sensitivity of skin snipping at low
nfection levels (Bottomley et al., 2016); in near-elimination set-
ings many infections are likely to be missed by skin snipping alone
the distribution of mf  in the skin is aggregated by contrast to the
andom Poisson distribution assumed by ONCHOSIM, a difference
hich also helps to explain the more rapid initial decline in preva-icted outcome (only in red hyperendemic categories, see Fig. 5) and the triangular
lots illustrate the density of the microﬁlarial prevalence predictions. The horizontal
d 5% (APOC, 2010).
lence projected by EPIONCHO compared with ONCHOSIM). That is,
EPIONCHO assumes more often than ONCHOSIM that mf  counts
are false-negative. Thus, application of the newly recommended
and more sensitive (serological) diagnostics, might enable earlier
detection of resurgence. Indeed, an epidemiological survey con-
ducted in 2014 in the River Gambia focus, including some but not
all of the communities included in this analysis, found a 2.5% sero-
prevalence among children aged 5–9 years (Wilson et al., 2016),
above the 0.1% threshold (upper 95% conﬁdence interval) in chil-
dren under 10 years recommended by the WHO  for veriﬁcation
of elimination (WHO, 2016). Hence, by this criterion, elimination
cannot be veriﬁed in the River Gambia focus and it is probable that
low-level transmission continues. Resurgence – based on parasito-
logical (mf) and entomological data – has also been reported in
Burkina Faso in a focus previously thought to have eliminated the
infection (Koala et al., 2017).
Notwithstanding the superior sensitivity of serological tech-
niques, how seroprevalence proﬁles in children manifest in
near-elimination settings and, more speciﬁcally, how the sero-
prevalence threshold (WHO, 2016) relates to transmission
breakpoints and the likelihood of elimination, is a subject of ongo-
ing research. A seroprevalence sub-model was recently included in
ONCHOSIM (Lont et al., 2017) and is under development for EPI-
ONCHO, in order to explore these issues more thoroughly. Early
analysis suggests that it is unlikely that a single seroprevalence
threshold (as an indicator of sustained elimination) will be valid
across diverse transmission settings (Lont et al., 2017). This would
concord with our previous analysis which indicated that in hyper-
endemic settings the proposed microﬁlarial prevalence thresholds
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ay  be too high – and hence pose a risk of resurgence if applied
o stop treatment – but probably too low in lower meso- and
ypoendemic settings (Stolk et al., 2015). Nevertheless, prevalence
hresholds (both serological and parasitological) are extremely
seful operational tools for decision-support in near-elimination
ettings if they can be appropriately constructed – and informed
sing mathematical models – to reﬂect the diversity of transmis-
ion settings and the vagaries of different diagnostic tools.
The greater circumspection on sustained elimination (and
ossible resurgence) indicated by EPIONCHO compared with
NCHOSIM reﬂects fundamental technical differences between the
wo models. One important difference is that the highly non-linear
elationship between microﬁlarial prevalence and ABR modelled
y EPIONCHO – reﬂecting additional density-dependent biologi-
al processes that are not included in ONCHOSIM (Basán˜ez et al.,
016) – supports a wide range of biting rates (Fig. 2a) and resultant
ransmission intensities. For example, EPIONCHO predicts an ABR
f approximately 20,000 to simulate 80% microﬁlarial prevalence
n the population aged ≥5 years. In ONCHOSIM, the correspond-
ng ABR is approximately 14,000. Thus, EPIONCHO requires higher
iting rates to simulate hyperendemicity, implying a higher risk
f resurgence if some residual infection remains after interven-
ion. Hence, the epidemiological data from some communities
re associated (by EPIONCHO) with conditions highly propitious
o transmission and a parasite population resilient to even long
nd intensive interventions. Resurgence is a probable projected
utcome in many putatively hyperendemic villages, especially in
he River Gambia focus in Senegal, where inferred ABRs tended
o be higher than in the River Bakoye focus. In ONCHOSIM, the
uch less non-linear ABR-prevalence relationship (Fig. 2b) ensures
ore homogeneity among inferred community transmission con-
itions, explaining why sustained elimination is the ubiquitous
odelled outcome for both foci. Furthermore, ONCHOSIM assumes
ess efﬁcient transmission than EPIONCHO at low intensities (due
o density-dependent parasite establishment; Basán˜ez et al., 2002)
nd a decline in mf  production with increasing worm age, both
aking resurgence less likely. A future priority is to understand
etter the discrepancy between the ABR-prevalence relationship
odelled by ONCHOSIM and the data collected by Renz and Wenk
1987) (where ABRs were measured as averages from multiple
ears and locations within and around communities, weighted by
he proportion of time community residents spent at these loca-
ions) and to revisit the density dependencies included within both
odels.
Another reason that resurgence is more likely in EPIONCHO
ompared to ONCHOSIM is the large population assumption inher-
nt to deterministic modelling approaches. Chance elimination by
tochastic demographic events like the death of (all) infected hosts
s not considered; elimination can only be achieved and sustained
y crossing the transmission breakpoint, the theoretical popula-
ion density below which the parasite population cannot sustain
tself and declines terminally towards extinction. This threshold
 which depends on vector abundance and the resulting ABR – is
hought to be very low for onchocerciasis (Basán˜ez et al., 2009),
nd human helminthiases more generally (Anderson and May,
991) This is because of the assumed polygamous mating system
a broadly-applied assumption in helminth transmission models,
xcepting schistosomes which are thought to form monogamous
ating pairs; May, 1977) and the degree of (adult) worm overdis-
ersion among hosts. A less efﬁcient mating system and a more
andomly (less aggregated) distribution of worms among hosts
ould make elimination by both models easier to reach. Addi-ionally, elimination in ONCHOSIM is also inﬂuenced by chance
stochastic) demographic events.
Typically, ONCHOSIM models a relatively small (400–440)
uman population such that stochastic events may  contributeics 18 (2017) 4–15
appreciably to the elimination outcome, especially when infec-
tion prevalence is low and because parasites are aggregated among
hosts; the death of the few individuals who harbour the bulk of
the parasite population can lead to an extinction event. However,
for the long and intensive interventions (biannual treatment fre-
quency for the River Gambia focus in Senegal) considered here, even
increasing the modelled population size to 800 individuals did not
alter the projected outcome of elimination across all 27 communi-
ties. However, future analyses should be conducted to understand
better the interplay between how assumptions on population size
might affect the minimum required duration or frequency of treat-
ment with ivermectin and to update current estimated timeframes
for onchocerciasis elimination among different endemicity settings
(Stolk et al., 2015).
Although the individual rural communities affected by
onchocerciasis tend to be relatively small, whether the large-
population assumption of EPIONCHO or the explicitly small (or
‘intermediate’ 800) population size modelled by ONCHOSIM is most
appropriate will crucially depend on the degree to which com-
munities are coupled by the movement of blackﬂies and people.
Neither EPIONCHO nor ONCHOSIM consider the spatial coupling of
proximate populations and especially the possible reintroduction
of infections from foci with ongoing transmission. The degree to
which individual communities are exposed to such foci will depend
on – in addition to blackﬂy and human movement – the geographi-
cal coverage of an intervention over the wider area and, in the case
of MDA, the treatment coverage in nearby communities. These fac-
tors, and the more general role of spatial transmission processes on
the dynamics, control and elimination of NTDs are poorly under-
stood, constituting a major gap in our understanding of how best
to reach and sustain elimination.
An important limitation of both models’ projections is that ento-
mological data from these foci – which between 2008 and 2010
were strongly indicative of transmission interruption (Diawara
et al., 2009; Traore et al., 2012) – were not used to train the mod-
els. This is because entomological surveillance was conducted away
from the communities at a few capture points, in a manner simi-
lar to OCP collection protocols during vector control. In principle,
these data could be – and ultimately should be – used to inform
model projections, but without detailed spatially-explicit models,
this would require assumptions that ﬂies from a limited num-
ber of collection points (4 in the River Bakoye and 3 in the River
Gambia foci respectively; Diawara et al., 2009) were representa-
tive of infectivity rates among ﬂies biting in communities. Linking
spatially-distinct epidemiological and entomological data (where
they exist) will be an important future challenge to reﬁning our
modelling projections.
A further technical limitation of the modelling approach is that
statistical discrepancies between model predictions and data –
given a particular parameter set, and assumed level of coverage
and adherence – were attributed to variations in community-
speciﬁc ABRs (which were estimated as part of the training
procedure). While such variations in ABR are entirely plausible
among geographically distinct populations, it is also possible that
community-speciﬁc coverage (and adherence rates) were outside
of the considered intervals (or the assumed point adherence rate)
in some communities. It is further plausible that underlying popu-
lation processes that were assumed to be constant between foci in
this analysis are somewhat geographically variable (e.g. responses
of O. volvulus to ivermectin in Ghana are distinct among circum-
scribed foci, possibly driven by geographically distinct parasite
genetic backgrounds; Frempong et al., 2016). Hence, some model-
data deviations could be alternatively ascribed to variations in
coverage, adherence or more fundamental population processes
rather than only to ABRs. Hence, without more precision (at the
individual community level) in the programmatic information, it
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s not possible to conclude that more epidemiological data always
ive a better ABR estimate, the key determinant of local transmis-
ion conditions. Indeed, a variety of other factors such as ecological
r environmental changes that might systematically have changed
BRs over the two decades of intervention also impede our ability
o estimate accurately local transmission conditions.
The results of this analysis together with our previous work
Stolk et al., 2015; Coffeng et al., 2014a; Turner et al., 2014) sug-
est that whether the 2020/2025 onchocerciasis elimination goals
ill be met  critically depends on when an intervention began;
ow intensively and effectively it was implemented (e.g. annual
r biannual MDA  with ivermectin; levels of coverage) and on the
ocal transmission conditions. In areas where the prevailing eco-
ogical conditions are highly propitious to transmission – including
any foci in West Africa where the initial endemic prevalence
as very high (O’Hanlon et al., 2016) and vector abundance has
eturned to original levels following OCP vector control (Lamberton
t al., 2014) – elimination by 2020 or 2025 may  be unfeasible with
vermectin alone. In such places (and elsewhere, such as where sub-
ptimal responses to ivermectin are persistent, Frempong et al.,
016), localized low-cost vector control should be considered as
 complement to MDA  alongside other so-called alternative treat-
ent strategies (WHO, 2015) including anti-wolbachial therapies
Walker et al., 2015) to accelerate progress towards the 2020/2025
oals. Emerging new treatment options (Kuesel, 2016), particularly
oxidectin which is similar but more efﬁcacious than ivermectin
Awadzi et al., 2014), present promising alternatives (Turner et al.,
015b). Where elimination appears to have been achieved, it is
ital that appropriate and robust PTS protocols are implemented
or conﬁrmation. Due to the poor sensitivity of the skin snip diag-
ostic, 3- to 5-year PTS periods of microﬁlarial prevalence may  not
e long enough to offer sufﬁcient conﬁdence that resurgence has
ot occurred. Models must now be used to explore how resurgence
anifests in seroprevalence and entomological data collected using
he latest and newly recommended diagnostic tools which will
ecome the cornerstone of future onchocerciasis surveillance in
frica.
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